Lupus anticoagulant and antibodies to β2-glycoprotein I, annexin V, and cardiolipin as a cause of recurrent spontaneous abortion

Fertility and Sterility

Volumn 88, Issue 5, 2007, Pages 1458-1461

  Mtiraoui, N ^a   Zammiti, W ^a   Fekih, M ^b   Hider, S ^b   Almawi, W Y ^c   Mahjoub, T ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOCORTIN 5; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RECURRENT ABORTION; SCREENING TEST; SPONTANEOUS ABORTION; THROMBOSIS; TROPHOBLAST;

ABORTION, HABITUAL; ABORTION, SPONTANEOUS; ADULT; ANNEXIN A5; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CARDIOLIPINS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR;

EID: 35648972078     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.01.026     Document Type: Article

References (18)

1. Lee J., Choi B.C., Cho C., Hill J.A., Baek K.H., and Kim J.W. Trophoblast apoptosis is increased in women with evidence of Th1 immunity. Fertil Steril 83 (2005) 1047-1049
2. Ulcova-Gallova Z., Krauz V., Novakova P., Milichovska L., Micanova Z., Bibkova K., et al. Anti-phospholipid antibodies against phosphatidylinositol, and phosphatidylserine are more significant in reproductive failure than antibodies against cardiolipin only. Am J Reprod Immunol 54 (2005) 112-117
3. Levy R.A., Avvad E., Oliveira J., and Porto L.C. Placental pathology in antiphospholipid syndrome. Lupus 7 Suppl 2 (1998) S81-S85
4. Meroni P.L., di Simone N., Testoni C., D'Asta M., Acaia B., and Caruso A. Antiphospholipid antibodies as cause of pregnancy loss. Lupus 13 (2004) 649-652
5. Gris J.C., Perneger T.V., Quere I., Mercier E., Fabbro-Peray P., Lavigne-Lissalde G., et al. Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study. Blood 102 (2003) 3504-3513
6. Heilmann L., von Tempelhoff G.F., and Kuse S. The influence of antiphospholipid antibodies on the pregnancy outcome of patients with recurrent spontaneous abortion. Clin Appl Thromb Hemost 7 (2001) 281-285
7. Ulcova-Gallova Z., Bouse V., Krizanovska K., Balvin M., Rokyta Z., and Netrvalova L. Beta 2-glycoprotein I is a good indicator of certain adverse pregnancy conditions. Int J Fertil Womens Med 46 (2001) 304-308
8. Matsubayashi H., Arai T., Izumi S., Sugi T., McIntyre J.A., and Makino T. Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil Steril 76 (2001) 694-699
9. Rand J., Eerden P.V., Wu X.X., and Chazotte C. Defective annexin A5 crystallization: a mechanism for pregnancy losses in the antiphospholipid syndrome. Thromb Res 115 Suppl 1 (2005) 77-81
10. Rai R.S., Regan L., Clifford K., Pickering W., Dave M., Mackie I., et al. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod 10 (1995) 2001-2005
11. Branch D.W., Silver R.M., Pierangeli S.S., van Leeuwen I., and Harris E.N. Antiphospholipid antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet Gynecol 89 (1997) 549-555
12. Sugi T., Matsubayashi H., Inomo A., Dan L., and Makino T. Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss. J Obstet Gynaecol Res 30 (2004) 326-332
13. Pengo V., Biasiolo A., Brocco T., Tonetto S., and Ruffatti A. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipids reactive antibodies. Thromb Haemost 75 (1996) 721-724
14. Tsakiris D.A., Yasikoff M.L., Wolf F., and Marbet G.A. Anticardiolipin antibodies do not seem to be associated with APC resistance in vivo or in vitro. Ann Hematol 71 (1995) 195-198
15. Bokarewa M.I., Wramsby M., Bremme K., and Blomback M. Variability of the response to activated protein C during normal pregnancy. Blood Coagul Fibrinolysis 8 (1997) 239-244
16. Gleicher N. Some thoughts on the reproductive autoimmune failure syndrome (RAFS) and Th-1 versus Th-2 immune responses. Am J Reprod Immunol 48 (2002) 252-254
17. Horkko S., Miller E., Dudl E., Reaven P., Curtiss L.K., Zvaifler N.J., et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 98 (1996) 815-825
18. Gharavi A.E., Pierangeli S.S., Levy R.A., and Harris E.N. Mechanisms of pregnancy loss in antiphospholipid syndrome. Clin Obstet Gynecol 44 (2001) 11-19